162 related articles for article (PubMed ID: 7749121)
1. Cord blood transplantation: implications for graft vs. host disease and graft vs. leukemia.
Harris DT
Blood Cells; 1994; 20(2-3):560-4; discussion 564-5. PubMed ID: 7749121
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the alloreactive capacity of human umbilical cord blood: implications for graft-versus-host disease.
Harris DT; LoCascio J; Besencon FJ
Bone Marrow Transplant; 1994 Oct; 14(4):545-53. PubMed ID: 7858529
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo assessment of the graft-versus-leukemia activity of cord blood.
Harris DT
Bone Marrow Transplant; 1995 Jan; 15(1):17-23. PubMed ID: 7742753
[TBL] [Abstract][Full Text] [Related]
4. Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation.
Risdon G; Gaddy J; Stehman FB; Broxmeyer HE
Cell Immunol; 1994 Mar; 154(1):14-24. PubMed ID: 8118883
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic responses of human umbilical cord blood.
Risdon G; Gaddy J; Broxmeyer HE
Blood Cells; 1994; 20(2-3):566-70; discussion 571-2. PubMed ID: 7749122
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactivity of umbilical cord blood and post-partum maternal peripheral blood with regard to HLA-haploidentical transplantation.
Harris DT; Schumacher MJ; LoCascio J; Booth A; Bard J; Boyse EA
Bone Marrow Transplant; 1994 Jul; 14(1):63-8. PubMed ID: 7951121
[TBL] [Abstract][Full Text] [Related]
7. The functional immaturity of dendritic cells can be relevant to increased tolerance associated with cord blood transplantation.
Encabo A; Solves P; Carbonell-Uberos F; Miñana MD
Transfusion; 2007 Feb; 47(2):272-9. PubMed ID: 17302774
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of the cytotoxic alloresponse of cord blood.
Barbey C; Irion O; Helg C; Chapuis B; Grand C; Chizzolini C; Jeannet M; Roosnek E
Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S26-30. PubMed ID: 9715879
[TBL] [Abstract][Full Text] [Related]
9. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
Johnson BD; Becker EE; Truitt RL
Biol Blood Marrow Transplant; 1999; 5(3):123-32. PubMed ID: 10392958
[TBL] [Abstract][Full Text] [Related]
10. Generation of HLA-A2 subtype specific cytotoxic T lymphocytes from cord blood used for cord blood stem cell transplantation.
Yazaki M; Takahashi T; Ito Y; Ito T; Mori C; Wada Y
Bone Marrow Transplant; 2000 Aug; 26(4):451-3. PubMed ID: 10982294
[TBL] [Abstract][Full Text] [Related]
11. Intracellular cytokine profile of cord blood T-, and NK- cells and monocytes.
Krampera M; Tavecchia L; Benedetti F; Nadali G; Pizzolo G
Haematologica; 2000 Jul; 85(7):675-9. PubMed ID: 10897117
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the alloreactivity and anti-leukemia reactivity of cord blood mononuclear cells.
Keever CA; Abu-Hajir M; Graf W; McFadden P; Prichard P; O'Brien J; Flomenberg N
Bone Marrow Transplant; 1995 Mar; 15(3):407-19. PubMed ID: 7599566
[TBL] [Abstract][Full Text] [Related]
13. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
Fowler DH; Breglio J; Nagel G; Eckhaus MA; Gress RE
J Immunol; 1996 Dec; 157(11):4811-21. PubMed ID: 8943383
[TBL] [Abstract][Full Text] [Related]
14. Immunological and functional differences between cord and peripheral blood.
Cohen SB; Madrigal JA
Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S9-12. PubMed ID: 9712484
[TBL] [Abstract][Full Text] [Related]
15. HLA-mismatched cord blood transplantation: immunological studies.
Vilmer E; Quelvennec E; Plouvier E; Denamur E; Rohrlich P; Elion J; Sterkers G
Blood Cells; 1994; 20(2-3):235-41. PubMed ID: 7538336
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
[TBL] [Abstract][Full Text] [Related]
17. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
Lin SJ; Kuo ML
Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
[TBL] [Abstract][Full Text] [Related]
18. Immune responses by cord blood cells.
Roncarolo MG; Bigler M; Ciuti E; Martino S; Tovo PA
Blood Cells; 1994; 20(2-3):573-85; discussion 585-6. PubMed ID: 7749123
[TBL] [Abstract][Full Text] [Related]
19. Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation.
Le Deist F; Raffoux C; Griscelli C; Fischer A
J Immunol; 1987 Jan; 138(2):423-7. PubMed ID: 3540121
[TBL] [Abstract][Full Text] [Related]
20. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
